Cargando…
A Different rTMS Protocol for a Different Type of Depression: 20.000 rTMS Pulses for the Treatment of Bipolar Depression Type II
In this open-label naturalistic study, we assess the feasibility, tolerability, and effectiveness of a repetitive transcranial magnetic stimulation protocol with a reduced total pulse number for treating patients suffering from bipolar disorder type II. All patients received one rTMS treatment sessi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505040/ https://www.ncbi.nlm.nih.gov/pubmed/36143081 http://dx.doi.org/10.3390/jcm11185434 |
_version_ | 1784796373176025088 |
---|---|
author | Koutsomitros, Theodoros van der Zee, Kenneth T. Evagorou, Olympia Schuhmann, Teresa Zamar, Antonis C. Sack, Alexander T. |
author_facet | Koutsomitros, Theodoros van der Zee, Kenneth T. Evagorou, Olympia Schuhmann, Teresa Zamar, Antonis C. Sack, Alexander T. |
author_sort | Koutsomitros, Theodoros |
collection | PubMed |
description | In this open-label naturalistic study, we assess the feasibility, tolerability, and effectiveness of a repetitive transcranial magnetic stimulation protocol with a reduced total pulse number for treating patients suffering from bipolar disorder type II. All patients received one rTMS treatment session of 1000 pulses for 20 consecutive working days, accumulating to 20.000 rTMS pulses applied over 4 weeks. We measured the patients’ symptoms before the start, halfway through, directly after, and one month after treatment. We quantified the depression symptoms using both the Beck depression inventory scale and the symptom checklist-90 depression subscale. Patients showed a significant reduction in depression symptoms directly after treatment and an even further reduction one month after treatment. The remission rates were at 26% halfway through treatment (after the 10th session), 61% directly after treatment (after the 20th session), and increased to 78% at the 1-month follow-up. Importantly, the protocol proved to be feasible and highly tolerable in this patient population, with no adverse effects being reported. Considering these positive results, further research should focus on replicating these findings in larger clinical samples with control groups and longer follow-up periods, while potentially adding maintenance sessions to optimize the treatment effect and stability for bipolar disorder type II patients. |
format | Online Article Text |
id | pubmed-9505040 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95050402022-09-24 A Different rTMS Protocol for a Different Type of Depression: 20.000 rTMS Pulses for the Treatment of Bipolar Depression Type II Koutsomitros, Theodoros van der Zee, Kenneth T. Evagorou, Olympia Schuhmann, Teresa Zamar, Antonis C. Sack, Alexander T. J Clin Med Article In this open-label naturalistic study, we assess the feasibility, tolerability, and effectiveness of a repetitive transcranial magnetic stimulation protocol with a reduced total pulse number for treating patients suffering from bipolar disorder type II. All patients received one rTMS treatment session of 1000 pulses for 20 consecutive working days, accumulating to 20.000 rTMS pulses applied over 4 weeks. We measured the patients’ symptoms before the start, halfway through, directly after, and one month after treatment. We quantified the depression symptoms using both the Beck depression inventory scale and the symptom checklist-90 depression subscale. Patients showed a significant reduction in depression symptoms directly after treatment and an even further reduction one month after treatment. The remission rates were at 26% halfway through treatment (after the 10th session), 61% directly after treatment (after the 20th session), and increased to 78% at the 1-month follow-up. Importantly, the protocol proved to be feasible and highly tolerable in this patient population, with no adverse effects being reported. Considering these positive results, further research should focus on replicating these findings in larger clinical samples with control groups and longer follow-up periods, while potentially adding maintenance sessions to optimize the treatment effect and stability for bipolar disorder type II patients. MDPI 2022-09-16 /pmc/articles/PMC9505040/ /pubmed/36143081 http://dx.doi.org/10.3390/jcm11185434 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Koutsomitros, Theodoros van der Zee, Kenneth T. Evagorou, Olympia Schuhmann, Teresa Zamar, Antonis C. Sack, Alexander T. A Different rTMS Protocol for a Different Type of Depression: 20.000 rTMS Pulses for the Treatment of Bipolar Depression Type II |
title | A Different rTMS Protocol for a Different Type of Depression: 20.000 rTMS Pulses for the Treatment of Bipolar Depression Type II |
title_full | A Different rTMS Protocol for a Different Type of Depression: 20.000 rTMS Pulses for the Treatment of Bipolar Depression Type II |
title_fullStr | A Different rTMS Protocol for a Different Type of Depression: 20.000 rTMS Pulses for the Treatment of Bipolar Depression Type II |
title_full_unstemmed | A Different rTMS Protocol for a Different Type of Depression: 20.000 rTMS Pulses for the Treatment of Bipolar Depression Type II |
title_short | A Different rTMS Protocol for a Different Type of Depression: 20.000 rTMS Pulses for the Treatment of Bipolar Depression Type II |
title_sort | different rtms protocol for a different type of depression: 20.000 rtms pulses for the treatment of bipolar depression type ii |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505040/ https://www.ncbi.nlm.nih.gov/pubmed/36143081 http://dx.doi.org/10.3390/jcm11185434 |
work_keys_str_mv | AT koutsomitrostheodoros adifferentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii AT vanderzeekennetht adifferentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii AT evagorouolympia adifferentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii AT schuhmannteresa adifferentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii AT zamarantonisc adifferentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii AT sackalexandert adifferentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii AT koutsomitrostheodoros differentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii AT vanderzeekennetht differentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii AT evagorouolympia differentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii AT schuhmannteresa differentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii AT zamarantonisc differentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii AT sackalexandert differentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii |